Spanish Registry of Pregnant Women With COVID-19
NCT04558996 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2020-09-22
Summary
Study title Spanish Registry of Pregnant Women with COVID-19 Protocol number and version Number 55/20. Version V8. Sponsors This registry is a project promoted by Dr. Oscar Martínez Pérez of the Obstetrics and Gynaecology department of the Puerta de Hierro University Hospital.
Principal investigator of the registry National coordinator: Dr. Óscar Martínez Pérez. Obstetrics and Gynaecology Department. Puerta de Hierro University Hospital. Majadahonda.
Epidemiologist: Maria Luisa de la Cruz Conti Researchers for each site: 100 sites from 32 Spanish provinces are included (Appendix 1) Funding Neither the hospitals nor the participating investigators will receive any financial compensation for their collaboration. A bank account has been opened at the hospital's Biomedical Research Foundation to receive donations: COV20/00021 - SARS-COV-2 and the COVID-19 disease Call financed by the Carlos III Institute of Health and co-financed with ERDF funds.
Abstract Rationale: Knowledge about the impact of the SARS-CoV-2 virus on pregnancy is still scarce and all current recommendations are based on less than 100 cases published in the literature. To identify moderate effects (such as vertical transmission, obstetric morbidity, foetal death, maternal or neonatal death) and to allow accurate risk estimates, larger sample sizes than those currently available are required.
Methods: Prospective observational study of pregnant women in whom SARS-CoV-2 infection is suspected at any time during pregnancy with positive test results for SARS-CoV-2, in order to create a registry of baseline characteristics of the pregnant woman, aspects related to the course of pregnancy and delivery, and related to the new-born, with an observation period of up to 14 days after delivery. Subsequently, several phased studies will be conducted to help establish and monitor the set of measures to improve the care of pregnant women.
Discussion: The national registry for COVID-19 in pregnancy described here is a tool for sharing and centralizing data related to exposures to SARS-CoV-2 during pregnancy in a structured way. It should speed up the process of prospectively obtaining a large unbiased data set and will collect information at national level.
Conditions
- Covid19
- Pregnancy Complications
- Premature Rupture of Membrane
- Abruptio Placentae
- Prelabor Rupture of Membranes
- Stillbirth
Sponsors & Collaborators
-
Hospital Universitario La Paz
collaborator OTHER -
Hospital Universitario 12 de Octubre
collaborator OTHER -
Hospital General Universitario Gregorio Marañon
collaborator OTHER -
Hospital Universitario La Fe
collaborator OTHER -
Puerta de Hierro University Hospital
lead OTHER
Principal Investigators
-
Oscar M Martinez Perez, Epidemiologist · HUHPH
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-03-31
Countries
- Spain
Study Locations
More Related Trials
-
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859 ·Status: COMPLETED
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED
-
COVID-19 Vaccines International Pregnancy Exposure Registry
NCT04705116 ·Status: RECRUITING
-
Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.
NCT05158868 ·Status: UNKNOWN
-
Clinical Study of Pregnant Women With COVID-19
NCT04701944 ·Status: UNKNOWN
-
Active Pregnancy Against COVID-19
NCT04563065 ·Status: UNKNOWN ·Phase: NA
-
Northeast COVID-19 and Pregnancy Study Group
NCT04462367 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.
NCT04315870 ·Status: UNKNOWN
-
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
NCT04319016 ·Status: UNKNOWN
-
Study of the Fetal and Maternal Microbiota in Preganant Women With Fetal Defect Growth
NCT04047966 ·Status: TERMINATED
-
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 ·Status: RECRUITING
-
Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection
NCT04492449 ·Status: UNKNOWN
-
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 ·Status: COMPLETED
-
Fetal, Obstetrics and Reproduction Genomics
NCT05720169 ·Status: UNKNOWN
-
Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
NCT06968117 ·Status: COMPLETED
-
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560 ·Status: UNKNOWN
-
COVID-19 Infection and Fetal-neonatal Outcomes
NCT04699578 ·Status: UNKNOWN
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Risks of COVID19 in the Pregnant Population
NCT04379284 ·Status: COMPLETED
-
Exploratory Study: COVID-19 and Pregnancy
NCT04647994 ·Status: UNKNOWN
-
Methylation of the PPARg Promoter Region in Pregnancy
NCT02395835 ·Status: COMPLETED
-
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866 ·Status: RECRUITING ·Phase: NA
-
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 ·Status: UNKNOWN
-
Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome
NCT07338279 ·Status: RECRUITING
-
COronaVirus Induced Acute Respiratory Disease Syndrome During PREGnancy
NCT05193526 ·Status: UNKNOWN